Edition:
United Kingdom

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

5.00USD
20 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.00
Open
$4.85
Day's High
$5.12
Day's Low
$4.85
Volume
46,807
Avg. Vol
114,388
52-wk High
$9.49
52-wk Low
$1.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.074
Jun '18 0.00 -0.107
Mar '18 0.00 -0.122
FY 2017 Dec '17 0.00 -0.073
Sep '17 0.00 -0.133
Jun '17 0.00 -0.139
Mar '17 0.00 -0.154
FY 2016 Dec '16 0.00 -0.130
Sep '16 0.00 -0.159
Jun '16 0.00 -0.201
Mar '16 0.00 -0.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.63 33.59
P/E High - Last 5 Yrs. -- 301.04 45.05
P/E Low - Last 5 Yrs. -- 83.19 24.37
Beta 2.59 0.93 0.91
Price to Sales (TTM) -- 119.19 5.69
Price to Book (MRQ) -- 14.53 5.11
Price to Tangible Book (MRQ) 14.70 13.73 6.54
Price to Cash Flow (TTM) -- 65.35 23.52
% Owned Institutions 11.19 13.41 1.86

Dividends

  Company industry sector
Dividend Yield -- 0.42 1.48
Dividend Yield - 5 Year Avg -- 0.33 1.50
Dividend 5 Year Growth Rate -- 2.84 5.09
Payout Ratio(TTM) -- 25.29 43.86

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 376.88 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 95.70 5.86
Sales - 5 Yr. Growth Rate -- 28.71 10.16
EPS (MRQ) vs Qtr. 1 Yr. Ago 30.96 28.13 21.17
EPS (TTM) vs TTM 1 Yr. Ago 31.23 -- --
EPS - 5 Yr. Growth Rate -- 32.53 10.63
Capital Spending - 5 Yr. Growth Rate -- 35.83 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.10 2.26
Current Ratio (MRQ) 2.66 5.34 3.09
LT Debt to Equity (MRQ) 0.00 35.90 11.53
Total Debt to Equity (MRQ) 0.00 37.76 15.71
Interest Coverage (TTM) -- -89.19 32.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.11 54.07
Gross Margin - 5 Yr. Avg. -- 48.16 51.83
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -543.09 11.80
Operating Margin (TTM) -- -781.87 4.85
Operating Margin - 5 Yr. Avg. -- -563.63 7.45
Pre-Tax Margin (TTM) -- -745.99 5.82
Pre-Tax Margin - 5 Yr. Avg. -- -568.88 7.86
Net Profit Margin (TTM) -- -746.96 2.08
Net Profit Margin - 5 Yr. Avg. -- -571.58 4.10
Effective Tax Rate (TTM) -- 25.08 23.39
Effective Tax Rate - 5 Yr. Avg. -- 20.19 24.13

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,493,787 905,637,302
Net Income/Employee (TTM) -2,651,714 826,583 107,327,405
Receivable Turnover (TTM) -- 19.51 5.95
Inventory Turnover (TTM) -- 2.77 3.63
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -134.62 -2.01 11.52
Return on Assets - 5 Yr. Avg. -90.24 2.45 12.71
Return on Investment (TTM) -181.73 -0.64 15.05
Return on Investment - 5 Yr. Avg. -102.11 1.26 16.50
Return on Equity (TTM) -1,032.02 0.08 16.62
Return on Equity - 5 Yr. Avg. -235.00 1.77 17.61
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.65 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Galectin Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 35.56 30.88 91 58
13 Week -0.41 -5.26 47 60
26 Week -14.98 -21.45 35 79
52 Week 141.58 104.76 91 46
YTD 149.03 118.70 92 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.58%
# of Holders: 68
Total Shares Held: 5,997,445
3 Mo. Net Change: 417,041
# New Positions: 13
# Closed Positions: 20
# Increased Positions: 35
# Reduced Positions: 35
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.